Profilo
Jeff S.
Hartness currently works at Corganics LP, as Director from 2022, Bryn Pharma LLC, as Director from 2022, and Apogee Therapeutics, Inc., as Chief Commercial Officer from 2024.
Mr. Hartness also formerly worked at Bausch Health Cos., Inc., as Executive VP-Generics and Government Affairs.
Mr. Hartness received his undergraduate degree from Hanover College.
Posizioni attive di Jeff Hartness
| Società | Posizione | Inizio |
|---|---|---|
| APOGEE THERAPEUTICS, INC. | Corporate Officer/Principal | 09/09/2024 |
Corganics LP
Corganics LP Medical DistributorsDistribution Services Manufactures and distributes natural topical pain analgesic cream | Direttore/Membro del Consiglio | 23/02/2022 |
Bryn Pharma LLC
Bryn Pharma LLC Medical SpecialtiesHealth Technology Develops bi-dose intranasal devices for patients with anaphylaxis | Direttore/Membro del Consiglio | 13/12/2022 |
Precedenti posizioni note di Jeff Hartness
| Società | Posizione | Fine |
|---|---|---|
| BAUSCH HEALTH COMPANIES INC. | Consigliere Generale | - |
Formazione di Jeff Hartness
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
Hanover College
Hanover College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bausch Health Cos., Inc.
Bausch Health Cos., Inc. Pharmaceuticals: OtherHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
Corganics LP
Corganics LP Medical DistributorsDistribution Services Manufactures and distributes natural topical pain analgesic cream | Distribution Services |
Bryn Pharma LLC
Bryn Pharma LLC Medical SpecialtiesHealth Technology Develops bi-dose intranasal devices for patients with anaphylaxis | Health Technology |
Apogee Therapeutics, Inc.
Apogee Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops therapies for immunological and inflammatory disorders | Health Technology |
















